Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Henrik Siboni"'
Publikováno v:
Pharmaceutics, Vol 16, Iss 6, p 733 (2024)
Cell mechanics is gaining attraction in drug screening, but the applicable methods have not yet become part of the standardized norm. This review presents the current state of the art for atomic force microscopy, which is the most widely available me
Externí odkaz:
https://doaj.org/article/0f2f66dbe0b447ec8105f5f9cdf32470
Autor:
Katja Fresacher-Scheiber, Ivana Ruseska, Henrik Siboni, Martin Reiser, Fabio Falsone, Leonhard Grill, Andreas Zimmer
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1829 (2022)
microRNAs represent promising drugs to treat and prevent several diseases, such as diabetes mellitus. microRNA delivery brings many obstacles to overcome, and one strategy to bypass them is the manufacturing of self-assembled microRNA protein nanopar
Externí odkaz:
https://doaj.org/article/b6acf0becb9448d0adb52993aeaa956f
Publikováno v:
Rosenlyst, M, Siboni, H & Rasmussen, S 2018, Socio-technical evolution . in T Ikegami, N Virgo, O Witkowski, M Oka, R Suzuki & H Iizuka (eds), ALife 2018 : Proceedings of the Artificial Life Conference 2018 . MIT Press, Artificial Life Conference Proceedings, vol. 30, pp. 99-100, ALife 2018, Tokyo, Japan, 23/07/2018 . https://doi.org/10.1162/isal_a_00023
Are we evolving into a new Post-Industrial epoch driven by the emerging living and intelligent technologies, spearheaded by the digital revolution? Or are we just entering a new period in the Industrial epoch, where we don’t need to radically updat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4607f5afd969e2dc16263b81194a7c3d
https://doi.org/10.1162/isal_a_00023
https://doi.org/10.1162/isal_a_00023